NPY4R

Chr 10

neuropeptide Y receptor Y4

Also known as: NPY4-R, PP1, PPYR1, Y4

The NPY4R protein is a G protein-coupled receptor that binds pancreatic polypeptide, neuropeptide Y, and peptide YY to regulate cAMP signaling. Mutations in NPY4R cause autosomal recessive intellectual disability with obesity, short stature, and behavioral abnormalities. This gene shows very low constraint against loss-of-function variants (pLI near 0, LOEUF 1.75), consistent with recessive inheritance requiring biallelic mutations.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
45
P/LP submissions
0%
P/LP missense
1.75
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryNPY4R
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 55 VUS of 155 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.75LOEUF
pLI 0.000
Z-score -0.17
OE 1.06 (0.641.75)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.14Z-score
OE missense 0.97 (0.851.10)
164 obs / 169.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE1.06 (0.641.75)
00.351.4
Missense OE0.97 (0.851.10)
00.61.4
Synonymous OE1.27
01.21.6
LoF obs/exp: 9 / 8.5Missense obs/exp: 164 / 169.1Syn Z: -1.80
DN
0.74top 25%
GOF
0.86top 5%
LOF
0.2484th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

155 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic15
VUS55
Likely Benign1
Benign49
30
Pathogenic
15
Likely Pathogenic
55
VUS
1
Likely Benign
49
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
30
0
30
Likely Pathogenic
0
0
15
0
15
VUS
0
35
20
0
55
Likely Benign
0
0
1
0
1
Benign
0
2
45
2
49
Total0371112150

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NPY4R · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →